Lista pubblicazioni 2003-2015
Lista Pubblicazioni
  • Spugnini EP, A Porrello. Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of biphasic electric pulses. J. Exp. Clin. Canc. Res. 2003; 22: 571-580.
  • Spugnini EP, Dragonetti E, Vincenzi B, Onori E, Citro G, Baldi A. Pulse mediated chemotherapy enhances local control and survival in a spontaneous canine mucosal melanoma model. Melanoma Res. 2006; 16: 23-27.
  • Spugnini EP, Baldi A, Vincenzi B, Bongiorni F, Bellelli C, Citro G, Porrello A. Intraoperative versus postoperative electrochemotherapy in soft tissue sarcomas: a preliminary study in a spontaneous feline model. Cancer Chemother Pharmacol. 2007; 59 (3): 375-381.
  • Spugnini EP, Vincenzi B, Baldi F, Citro G, Baldi A. Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors. Anticancer Res. 2006; 26(6B) 4585-4889.
  • Spugnini EP, Vincenzi B, Citro G, Santini D, Dotsinsky I, Mudrov N, Montesarchio V, Laieta MT, Esposito V,Baldi A . Adjuvant electrochemotherapy for the treatment of incompletely excised spontaneous canine sarcomas. In Vivo 2007; 21: 819-822.
  • Spugnini EP, Filipponi M, Romani L, Dotsinsky I, Mudrov N, Baroni A, Ruocco E, Lieta MT, Montesarchio V,Cassandro R, Citro G, Baldi A. Local control and distant metastases after electrochemotherapy of a canine anal melanoma. In Vivo 2007; 21: 897-900.
  • Spugnini EP, Citro G, Mellone P, Dotsinsky I, Mudrov N, Baldi A. Electrochemotherapy for localized lymphoma: a preliminary study in companion animals. J Exp Clin Cancer Res 2007; 26: 343-346.
  • Spugnini EP, Arancia G, Porrello A, Colone M, Formisano G, Stringaro A, Citro G, Molinari A. Ultrastructural modifications induced by electroporation on melanoma xenografts. Micr Res Tech.2007; 70: 1041-1050.
  • Spugnini EP, Citro G, Dotsinsky I, Mudrov N, Mellone P, Baldi A. Ganglioneuroblastoma in a cat: a rare neoplasm treated with electrochemotherapy. Vet J 2008; 178: 291-293.
  • Spugnini EP, Vincenzi B, Citro G, Tonini G, Dotsinsky I, Mudrov N, Baldi A. Electrochemotherapy for the treatment of squamous cell carcinoma in cats: a preliminary report. Vet J 2009; 179: 117-120.
  • Spugnini EP, Vincenzi B, Betti G, Cordahi F, Dotsinsky I, Mudrov N, Citro G, Baldi A. Surgery and electrochemotherapy for high grade soft tissue sarcoma in a dog. Vet Rec 2008; 162: 186-188.
  • Spugnini EP, Dotsinsky I, Mudrov N, Cardosi G, Citro G, Baldi A. Biphasic pulses enhance bleomycin efficacy in a spontaneous canine perianal tumors model. J Exp Clin Cancer Res 2007; 26: 483-487.
  • Spugnini EP, Dotsinsky I, Mudrov N, Bufalini M, Giannini G, Citro G, Feroce F, Baldi A. Adjuvant electrochemotherapy for incompletely excised anal sac carcinoma in a dog. In Vivo 2008; 22:. 47-50
  • Spugnini EP, Dotsinsky I, Mudrov N, De Luca A, Codini C, Citro G, D’ Avino A, Baldi A. Successful rescue of an apocrine gland carcinoma metastatic to the cervical lymph nodes by mitoxantrone coupled with trains of permeabilizing electric pulses (electrochemotherapy). In Vivo 2008; 22: 51-54
  • Spugnini EP, Filipponi M, Romani L, Dotsinsky I, Mudrov N, Citro G, Baldi A. Bilateral pleomorphic rhabdomyosarcoma in a cat treated with electrochemotherapy. J Small An Pract 2010; 51(6):330-2
  • Spugnini EP, Vincenzi B, Citro G, Baldi A. Evaluation of cisplatin (CDDP) as a electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs. J Vet Intern Med, 2011; 25: 407-411.
  • Spugnini EP, Biroccio A, De Mori R, Scarsella M, D’ Angelo C, Baldi A, Leonetti C. Electroporation increases antitumoral efficacy of the bcl-2 antisense g3139 and chemotherapy in a human melanoma xenograft. J Trasl Med. 2011;9:152.
  • Spugnini EP, D’ Alterio GL, Dotsinsky I, Mudrov T, Dragonetti E, Murace G, Citro G, Baldi A. Electrochemotherapy for the treatment of multiple melanomas in a horse. J Eq Vet Sci. 2011; 31: 430-433.
  • Spugnini EP, Renaud SM, Buglioni S, Carocci F, Dragonetti E, Murace R, Cardelli P, Vincenzi B, Baldi A, CitroG. Electrochemotherapy with cisplatin enhances local control after surgical ablation of fibrosarcoma in cats: an approach to improve the therapeutic index of highly toxic chemotherapy drugs. J Transl Med. 2011; 9:152.
  • Spugnini EP, Cardillo I, Fanciulli M, Crispi S, Baldi A. Electroporation as a strategy to promote HtrA1 gene uptake and chemotherapy efficacy in a mouse model of mesothelioma. Front Biosci 2013; 5:974-81.
  • Spugnini EP, Di Tosto G, Salemme S, Pecchia L, Fanciulli M, Baldi A. Electrochemotherapy for the treatment of recurring aponeurotic fibromatosis in a dog. Can Vet J 2013; 54: 606-608.
  • Scacco L, Bolaffio C, Romano A, Fanciulli M, Baldi A, Spugnini EP. Adjuvant electrochemotherapy increases local control in a recurring equine anal melanoma. J Eq Vet Sci. 2013; 33: 637-639.
  • Spugnini EP, Melillo A, Quagliuolo L, Boccellino M, Vincenzi B, Pasquali P, Baldi A. Definition of novel electrochemotherapy parameters and validation of their in vitro and in vivo effectiveness. J Cell Physiol. 2014 Sep;229(9):1177-81. doi: 10.1002/jcp.24548. PubMed PMID: 24403005.
  • Spugnini EP, Baldi A. Electrochemotherapy in veterinary oncology: from rescue to first line therapy. Methods Mol Biol. 2014;1121:247-56.doi:10.1007/978-1-4614-9632-8_22. Review. PubMed PMID: 24510829.
  • Lanza A, Baldi A, Spugnini EP. Surgery and electrochemotherapy for the treatment of cutaneous squamous cell carcinoma in a yellow-bellied slider (Trachemys scripta scripta). J Am Vet Med Assoc. 2015 Feb 15;246(4):455-7. doi:10.2460/javma.246.4.455. PubMed PMID: 25632821.
Pubblicazioni con Impact Factor
  1. Spugnini EP, Donald E. Thrall, G. Sylvester Price , Nicholas J. Sharp, Karen Munana , Rodney L. Page . Primary irradiation of canine intracranial masses. Vet Radiol Ultras. 2000; 41: 377-80. 
  2. Spugnini EP, A Bartolazzi, D Ruslander. Seminoma with cutaneous metastases in a dog. J Am  An Hosp Assoc . 2000; 36: 253-6. 
  3. Spugnini EP, D Ruslander, A Bartolazzi. Extraskeletal osteosarcoma in a cat.  J Am Vet Med Assoc 2001; 219: 60-62.
  4. Spugnini EP. Use of hyaluronidase for the treatment of extravasation of chemotherapeutic agents in six dogs. J Am Vet Med Assoc 2002; 221: 1437-1440.
  5. Spugnini EP, A Porrello. Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of biphasic electric pulses. J. Exp. Clin. Canc. Res. 2003; 22: 571-580.
  6. Porrello A, Cardelli P, Spugnini EP. Pet models in cancer research: general principles. J. Exp. Clin. Canc. Res. 2004; 23, 2: 5-17.
  7. Spugnini EP, Citro G, Porrello A. Rational design of new electrodes for electrochemotherapy. J. Exp. Clin. Canc. Res 2005; 24: 245-254.
  8. Cardillo I, Spugnini EP,Verdina A, Galati R, Citro G, Baldi A. Cox and mesothelioma: an overview. Histol Histopathol. 2005; 20: 1267-1274.
  9. Spugnini EP, Porrello A, Citro G, Baldi A. Cox-2 overexpression in canine tumors: potential therapeutic targets in oncology. Histol Histopathol. 2005; 20: 1309-1312.
  10. Campioni M, Santini D, Tonini G, Murace R, Dragonetti E, Spugnini EP, Baldi A. Role of APAF-1, a key regulator of apoptosis, in melanoma progression and chemoresistance. Exp Dermatol.2005; 14: 811-818.
  11. Spugnini EP, Dragonetti E, Murace R, Esposito V, Groeger AM, Baldi A. A spontaneous model of intestinal melanoma in dogs. In Vivo, 19: 1051-1054, 2005.
  12. Porrello A, Cardelli P, Spugnini EP. Oncology of companion animals as a model for humans: an overview of tumor histotypes. J  Exp Clin Cancer Res. 2006; 25: 97-106.
  13. Spugnini EP, Esposito V, Groeger AM, Cassandro R, Chirianni A, Baldi A. Effects of Indinavir in a preliminary phase I study on dogs with stage III splenic hemangiosarcoma. In Vivo. 20: 125-128, 2006.
  14. Esposito V, Palescandalo E, Spugnini EP, Montesarchio V, De Luca A, Cortese G, Baldi A, Chirianni A. Evaluation of antitumor properties of indinavir in a murine model of epatocarcinoma. Clin Cancer Res. 2006; 12 :  2634-2639.
  15. Spugnini EP, Dragonetti E, Vincenzi B, Onori E, Citro G, Baldi A. Pulse mediated chemotherapy enhances local control and survival in a spontaneous canine mucosal melanoma model.Melanoma Res. 2006; 16: 23-27.
  16. Spugnini EP, Baldi A, Vincenzi B, Bongiorni F, Bellelli C, Citro G, Porrello A. Intraoperative versus postoperative electrochemotherapy in soft tissue sarcomas: a preliminary study in a spontaneous feline model. Cancer Chemother Pharmacol. 2007; 59 (3): 375-381.
  17. Baldi A, Colloca E,  Spugnini EP. Lomustine for the treatment of gastrointestinal mast cell tumor in a dog. J Sm Anim Pract 2006; 47: 465-467.
  18. Baldi A, Spugnini EP. Thoracic hemangiopericytoma in a cat. Vet Rec 2006; 159: 598-599.
  19. Spugnini EP, Bosari S, Citro G, Cognetti F, Baldi A. Human malignant mesothelioma: molecular mechanisms of pathogenesis and progression. Int J Biochem Cell Biol  2006; 38: 2000-2004.
  20. Spugnini EP, Cardillo I, Verdina A , Crispi S, Saviozzi S, Calogero R, Nebbioso A, Altucci L, Cortese G, Galati R, Chien J, Shridhar V, Vincenzi B, Citro G, Cognetti F, Sacchi A, Baldi A. Piroxicam inhibits the growth of mesothelioma cells and enhances platinum based chemotherapy in a mouse xenograft model of peritoneal mesothelioma. Clin Cancer Res 2006; 12: 6133-6143.
  21. Esposito V, Campioni M, De Luca A, Spugnini EP, Baldi F, Cassandro R, Mancini A, Vincenzi B, Groeger A, Caputi M, Baldi A. Analysis of HTRA1 serine protease expression in human lung cancer.Anticancer Res. 2006; 26(5A): 3455-3459.
  22. Spugnini EP, Vincenzi B, Baldi F, Citro G, Baldi A. Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors. Anticancer Res. 2006; 26(6B) 4585-4889.
  23. Spugnini EP, Vincenzi B, Citro G, Santini D, Dotsinsky I, Mudrov N, Montesarchio V, Laieta MT, Esposito V, Baldi A . Adjuvant electrochemotherapy for the treatment of incompletely excised spontaneous canine sarcomas. In Vivo 2007; 21: 819-822.
  24. Spugnini EP, Filipponi M, Romani L, Dotsinsky I, Mudrov N, Baroni A, Ruocco E, Lieta MT, Montesarchio V, Cassandro R, Citro G, Baldi A. Local control and distant metastases after electrochemotherapy of a canine anal melanoma. In Vivo 2007; 21: 897-900.
  25. Spugnini EP, Citro G, Mellone P, Dotsinsky I, Mudrov N, Baldi A. Electrochemotherapy for localized lymphoma: a preliminary study in companion animals. J  Exp Clin Cancer Res 2007; 26: 343-346.
  26. Spugnini EP, Baldi F, Mellone P, Feroce F, Bonetto F, Citro G, Baldi A. Patterns of tumor responses in canine and feline cancer patients treated with electrochemotherapy. J Transl Med. 2007; Oct 2;5(1):48.
  27. Turco MC, Lamberti A, Bisogni R, Romano MF, Petrella A, Ammirante M, Rosati A, Davenia M, Arra C, Spugnini E, Bonelli P, Venuta S. Modulation of cell apoptosis by AIR. Leukemia 2007; 21: 2557-2559.
  28. Spugnini EP, Arancia G, Porrello A, Colone M, Formisano G, Stringaro A, Citro G, Molinari A. Ultrastructural modifications induced by “electroporation” on melanoma xenografts. Micr Res Tech.2007; 70: 1041-1050.
  29. Spugnini EP, Citro G, Dotsinsky I, Mudrov N, Mellone P, Baldi A. Ganglioneuroblastoma in a cat: a rare neoplasm treated with electrochemotherapy. Vet J 2008; 178: 291-293.
  30. Spugnini EP, Vincenzi B, Citro G, Tonini G, Dotsinsky I, Mudrov N, Baldi A. Electrochemotherapy for the treatment of squamous cell carcinoma in cats: a preliminary report. Vet J 2009; 179: 117-120.
  31. Spugnini EP, Pagotto A, Zazzera F, D’ Avino A, Caruso G, Baldi A. Cutaneous T cell lymphoma in an African hedgehog (Atelerix Albiventris). In Vivo. 2008; 22: 43-46.
  32. Spugnini EP, Citro G, Baldi A. Potential role of electrochemotherapy for the treatment of soft tissue sarcoma: first insights from preclinical studies in animals. Int J Biochem. Cell Biol.  2008; 40: 159-163.
  33. Spugnini EP, Vincenzi B, Betti G, Cordahi F, Dotsinsky I, Mudrov N, Citro G, Baldi A. Surgery and electrochemotherapy for high grade soft tissue sarcoma in a dog. Vet Rec 2008; 162: 186-188.
  34. Spugnini EP, Dotsinsky I, Mudrov N, Cardosi G,  Citro G, Baldi A. Biphasic pulses enhance bleomycin efficacy in a spontaneous canine perianal tumors model. J  Exp Clin Cancer Res 2007; 26: 483-487.
  35. Spugnini EP, Campioni M, D’Avino A, Caruso G, Citro G, Baldi A. Cell-cycle molecules in mesothelioma: an overview. J  Exp Clin Cancer Res 2007; 26: 443-449.
  36. Spugnini EP, Dotsinsky I, Mudrov N, Bufalini M, Giannini G,  Citro G, Feroce F, Baldi A. Adjuvant electrochemotherapy for incompletely excised anal sac carcinoma in a dog. In Vivo 2008; 22:. 47-50
  37. Spugnini EP, Dotsinsky I, Mudrov N, De Luca A, Codini C, Citro G, D’ Avino A, Baldi A. Successful rescue of a apocrine gland carcinoma metastatic to the cervical lymph nodes by mitoxantrone coupled with trains of permeabilizing electric pulses (electrochemotherapy). In Vivo 2008; 22: 51-54
  38. Spugnini EP, Crispi S, Scarabelli A, Caruso G, Citro G, Baldi A. Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations. J Exp Clin Cancer Res 2008; 27: 6.
  39. Spugnini EP, Vincenzi B, Caruso G, Baldi A, Citro G, Santini D, Tonini G. Zoledronic acid for the treatment of appendicular osteosarcoma in a dog. J Sm An Pract. 2009; 59: 44-46.
  40. Baldi A, Mottolese M, Vincenzi B, Campioni M, Mellone P, Di Martino M,Di Crescenzo VC, Visca P, Menegozzo S, Spugnini EP, Citro G, Ceribelli A, Mirri A, Chien J, Schridhar V,  Ehrmann M, Santini M, Facciolo F. The serine protease HTRA 1 is a novel prognostic factor for human mesothelioma. Pharmacogenomics 2008; 9: 1069-1077.
  41. Spugnini EP, Dotsinsky I, Mudrov N, Citro G, D’ Avino A, Baldi A. Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumor model of chemoresistance: Sticker sarcoma.J Exp Clin Cancer Res 2008; 27: 58.
  42. Campioni M, Ambrogi V, Pompeo E, Citro G, Castelli M, Spugnini EP, Gatti A, Cardelli P, Lorenzon L, Baldi A, Mineo TC. Identification of genes down-regulated during lung cancer progression: a cDNA array study. J Exp Clin Cancer Res. 2008 Sep 15;27:38.
  43. Assin R, Baldi A, Citro G, Spugnini EP. Prostate as sole unusual recurrence site of lymphoma in a dog. In Vivo. 2008; 22: 755-757.
  44. Spugnini EP, Dotsinsky I, Mudrov N, Citro G, Cardelli P, Caruso G, Baldi A. Electrochemotherapy-Induced radiation recall in a cat. In Vivo. 2008; 22: 751-753.
  45. Spugnini EP, Gargiulo M, Assin R, D’ Avino A, Mellone P, Cardelli P, Citro G, Baldi A. Adjuvant carboplatin for the treatment of intestinal carcinoid in a dog. In Vivo. 2008; 22: 759-761.
  46. Spugnini EP, Citro G, Baldi A. Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans. J Exp Clinical Cancer Res 2009; 28: 114.
  47. Crispi S, Cardillo I, Spugnini EP, Citro G, Menegozzo S, Baldi A. Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets. Curr Cancer Drug Targets. 2010; 10(1):19-26
  48. Spugnini EP, Filipponi M, Romani L, Dotsinsky I, Mudrov N, Citro G, Baldi A. Bilateral pleomorphic rhabdomyosarcoma in a cat treated with electrochemotherapy. J Small An Pract 2010; 51(6):330-2
  49. Signorile PG, Spugnini EP, Mita L, Mellone P, D’Avino A, Bianco M, Diano N, Caputo L, Rea F, Viceconte R, Portaccio M, Viggiano E, Citro G, Pierantoni R, Sica V, Vincenzi B, Mita DG, Baldi F, Baldi A. Prenatal exposure of mice to bisphenol a elicits an endometriosis-like phenotype in female offspring. Gen Comp Endocrinol  2010 168(3):318-325.
  50. Spugnini EP, Mezzanotte F, Freri L, Betti G, Citro G, Baldi A. Cyproterone acetate-induced mammary carcinoma in two male cats. J Feline Med Surg  2010;12: 515-516.
  51. Spugnini EP, Citro G, Fais S. Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy. J Exp Clin Cancer Res. 2010 May 8;29:44.
  52. Aulino P, Berardi E, Cardillo VM, Rizzuto E, Perniconi B, Ramina C, Padula F, Spugnini EP, Baldi A, Faiola F, Adamo S, Coletti D. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer. 2010; 10:363.
  53. Baldi A, De Luca A, Esposito V, Campioni M, Spugnini EP, Citro G. Tumor suppressors and cell-cycle proteins in lung cancer. Pathology Research International. 2011; 2011: 605042.
  54. Spugnini EP, Vincenzi B, Citro G, Baldi A. Evaluation of cisplatin (CDDP) as a electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs. Journal of Veterinary Internal Medicine, 2011; 25: 407-411.
  55. Spugnini EP, Biroccio A, De Mori R, Scarsella M, D’ Angelo C, Baldi A, Leonetti C. Electroporation increases antitumoral efficacy of the bcl-2 antisense g3139 and chemotherapy in a human melanoma xenograft. Journal of Translational Medicine. 2011;9:152.
  56. Spugnini EP, D’ Alterio GL, Dotsinsky I, Mudrov T, Dragonetti E, Murace G, Citro G, Baldi A. Electrochemotherapy for the treatment of multiple melanomas in a horse. Journal of Equine Veterinary Science. 2011; 31: 430-433.
  57. Mara Campioni, Anna Severino, Lucrezia Manente, Antonio De Luca, Raffaele La Porta, Antonio Vitiello, Paola Fiore, Stefano Toldo, Enrico P. Spugnini, Marco G. Paggi, Alfonso Baldi. Identification of protein-protein interactions of human HtrA1. Frontiers in Bioscience. 2011; 3:1493-1499.
  58. Alfonso Baldi, Maria Rosaria Boccellino, Aldo Donizetti, Maria Teresa Piccolo, Raffaele La Porta, Lucio Quagliuolo, Enrico P. Spugnini, Irene Cardillo, Francesca Cordero, Gennaro Citro, Massimo Menegozzo, Raffaele A. Calogero, Stefania Crispi. Apoptosis induced by Piroxicam plus Cisplatin combined treatment is triggered by p21 overexpression in mesothelioma. PlosOne, 2011;6(8):e23569.
  59. Mita L, Baldi A, Diano N, Viggiano E, Portaccio M, Nicolucci C, Grumiro L, Menale C, Mita DG, Spugnini EP, Viceconte R, Citro G, Pierantoni R, Sica V, Marino M, Signorile PG, Bianco M. Differential accumulation of BPA in some tissues of offspring of Balb-C mice exposed to different BPA doses. Environ Toxicol Pharmacol. 2011; 33(1):9-15.
  60. Spugnini EP, Renaud SM, Buglioni S, Carocci F, Dragonetti E, Murace R, Cardelli P, Vincenzi B, Baldi A, Citro G. Electrochemotherapy with cisplatin enhances local control after surgical ablation of fibrosarcoma in cats: an approach to improve the therapeutic index of highly toxic chemotherapy drugs. J Transl Med. 2011; 9:152.
  61. Enrico P Spugnini, Alfonso Baldi, Sabrina Buglioni, Francesca Carocci, Giulia Milesi de Bazzichini, Gianluca Betti, Ilaria Pantaleo, Francesco Menicagli, Gennaro Citro and Stefano Fais. Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors. J. Transl Med. 2011; 9:221.
  62. Pietro G. Signorile, Enrico P. Spugnini, Gennaro Citro, Rosa Viceconte, Bruno Vincenzi, Feliciano Baldi, Alfonso Baldi. Endocrine disruptors in utero cause ovarian damages linked to endometriosis Baldi, Frontiers in Bioscience. 2012; 4:1724-30.
  63. Stefania Meschini, Maria Condello, Pasquale Lista, Bruno Vincenzi, Alfonso Baldi, Gennaro Citro, Giuseppe Arancia, Enrico P. Spugnini. Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo) European Journal Of Cancer 2012 Sep;48(14):2236-43.
  64. Vincenzo Esposito, Alessandra Verdina, Enrico P. Spugnini, Rosaria Viglietti, Roberto Parrella, Pasquale Pagliano, Giovanni Parrella,  Rossella Galati, Antonio De Luca, Alfonso Baldi, Vincenzo Montesarchio, Antonio Chirianni.Amprenavir PI3K/AKT independent anti-tumoral properties in an in vitro and in vivo model of epatocarcinoma. J Cell Physiol accepted for publication.
  65. Spugnini EP, Fanciulli M, Citro G, Cardelli P, Baldi A. Electrochemotherapy in veterinary patients: a model for the implementation of loco-regional therapies in humans. Future Oncology 2012 Jul;8(7):829-37.
  66. Spugnini EP, Cardillo I, Fanciulli M, Crispi S, Vincenzi B, Boccellino M, Quagliuolo L, Baldi A. Electroporation as a strategy to promote HtrA1 gene uptake and chemotherapy efficacy in a mouse model of mesothelioma. Frontiers in Bioscience accepted for publication.
  67. Scacco L, Bolaffio C, Romano A, Fanciulli M, Baldi A,Spugnini EP. Adjuvant electrochemotherapy increases local control in a recurring equine anal melanoma.Journal of Equine Veterinary Science. Accepted for publication.
  68. Spugnini EP, Di Tosto G, Salemme S, Pecchia L, Fanciulli M, Baldi A. Electrochemotherapy for the treatment of recurring aponeurotic fibromatosis in a dog.Canadian Veterinary JournalUnder revision
Pubblicazioni senza Impact Factor
  1. Spugnini EP, Page RL, Thrall DE. Canine Brain Tumors: a brief update. Veterinary Cancer Society Newsletter.1995. Volume 19, #3: 7-9.
  2. Spugnini EP, Citro G, Baldi A. Cox Inhibitors as Potential Chemotherapic Drugs for Mesothelioma. Curre Resp Rev  2007; 3: 15-18.
  3. Rosatelli P, Menicagli F, Citro G, Baldi A, Spugnini EP. Long term survival in a cat with pancreatic carcinoma and splenic involvement after surgical excision.Case Reports in Veterinary Medicine2011; pp 1-3.
  4. Spugnini EP. Improved delivery of anticancer molecules by means of biphasic electric pulses in laboratory animals and preclinical studies in companion animals with spontaneous neoplasms. Ph D thesis; February 2006, Sofia, Bulgaria.
Libri
  • Spugnini EP, Baldi A, Citro G. Pulse mediated chemotherapy (electrochemotherapy) studies in animals and their translation to humans. Recent Res. Devel. Pharmacol. pp 1-28, 2006, Research Signpost, Kerala India.
  • Spugnini EP, Seiler G, Keene B. Canine mesothelioma: an epidemiological and preclinical model. In: Baldi A (Editor) “Mesothelioma from benchside to the clinic” Nova Science NY. 2008, pp 537-546
  • Spugnini EP et al. Capitoli 7,13,14, 15. In: Electroporation in Laboratory and Clinical Investigations. Edited by Nova Science, New York..